Journals / Avrupa Bilim ve Teknoloji Dergisi / 2022 / Sayı: 41

Current Medical Nutrition Therapy and Its Importance in Children with Duchenne Muscular Dystrophy Abstract

Duchenne Musküler Distrofi’si olan Çocuklarda Güncel Tıbbi Beslenme Tedavisi ve Önemi

Pages
436–441
Publication Date
2022-11-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this reason, nutritional problems in children with DMD should be determined at an early stage and appropriate treatment approaches should be planned, and it would be more appropriate to continue the treatment with a multidisciplinary team.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Duchenne muscular dystrophy (DMD), a progressive muscle wasting disease, is an important neuromuscular disease that occurs due to dystrophin protein deficiency.
📊
Key Findings & Data:It is noteworthy that in these patients, problems in functions such as breathing, heart and nutrition increase in advancing age.
💡
Conclusion & Impact:For this reason, nutritional problems in children with DMD should be determined at an early stage and appropriate treatment approaches should be planned, and it would be more appropriate to continue the treatment with a multidisciplinary team.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:duchenne musküler distrofi · çocuk · obezite

Abstract

Duchenne muscular dystrophy (DMD), a progressive muscle wasting disease, is an important neuromuscular disease that occurs due to dystrophin protein deficiency. It is noteworthy that in these patients, problems in functions such as breathing, heart and nutrition increase in advancing age. These problems, which increase with age, increase the risk of obesity and malnutrition and cause the prognosis of the disease to worsen. Although there is no definitive treatment for DMD, in addition to treatment, it is important to protect patients from obesity and malnutrition, and to make dietary changes in line with the presence of nutrition and gastrointestinal problems. Establishing a diet that will help protect muscle integrity in patients with DMD plays an important role in reducing early-onset bone health problems and their negative effects on weight. At the same time, compliance with the applied diet, not only for the patient with DMD, but also for the whole family, will enable the child to get used to and maintain this order more easily. For this reason, nutritional problems in children with DMD should be determined at an early stage and appropriate treatment approaches should be planned, and it would be more appropriate to continue the treatment with a multidisciplinary team.

Özet

İlerleyici bir kas erimesi hastalığı olan Duchenne musküler distrofisi (DMD), distrofin proteini eksikliğine bağlı olarak ortaya çıkan önemli nöromusküler bir hastalıktır. Bu hastalarda ilerleyen yaş dönemlerinde solunum, kalp, beslenme gibi fonksiyonlarında sorunların arttığı dikkati çekmektedir. Yaşla birlikte artan bu sorunlar, obezite ve yetersiz beslenme gelişme riskini artırmakta ve hastalığın prognozunun daha kötüye gitmesine neden olmaktadır. DMD hastalığının kesin tedavisi olmamakla birlikte tedaviye ek olarak, hastaların obezite ve malnütrisyondan korunması, beslenme ve gastrointestinal sorunların varlığının doğrultusunda diyetsel değişikliklerinin yapılması önem taşımaktadır. DMD’li hastalarda kas bütünlüğünü korumaya yardımcı olacak bir beslenme düzeninin oluşturulması, erken yaşta başlayan kemik sağlığı problemlerini ve kilo üzerindeki olumsuz etkilerini azaltmada önemli rol oynamaktadır. Aynı zamanda uygulanan beslenme düzenine, sadece DMD’li hastanın değil tüm ailenin uyması, çocuğun bu düzene daha kolaylıkla alışmasını ve sürdürmesini sağlayacaktır. Bu nedenle DMD’li çocuklarda beslenme sorunları erken dönemde belirlenerek uygun tedavi yaklaşımları planlanmalı ve bu konuda multidisipliner bir ekiple tedavinin sürdürülmesi daha uygun olacaktır.

🔖

Cite This Article

EKİCİ, B. Y., KÖSEOĞLU, S. Z. A. (2022). Current Medical Nutrition Therapy and Its Importance in Children with Duchenne Muscular Dystrophy Abstract. Avrupa Bilim ve Teknoloji Dergisi, Sayı: 41, 436–441. https://ajindex.com/articles/875569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ann-Charlott Söderpalm, M. A.-C.-K.-E. (2007). Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromusculer Disorders, 17(11-12), 919-928. Amerikan Pediatri Akademisi Beslenme Komitesi. Pediatrik Obezite. İçinde: Kleinman RE, Greer FR, editörler. Pediatrik beslenme. 7. Elk Grove Village, IL: Amerikan Pediatri Akademisi; 2014. s. 827. Askeri Türken, S. V. (2021). Duchenne Musküler Distrofili Hastalarda Değerlendirme ve Beslenme. Fizyoterapide Güncel Yaklaşımlar, Bölüm 4. Beth N Ogata, D. H. (2014). Position of the Academy of Nutrition and Dietetics: nutrition guidance for healthy children ages 2 to 11 years. J Acad Nutr Diet, 114(8), 1257-76.
  2. David J Birnkrant, K. B. (2018). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol, 17(3), 251-267.
  3. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). National Academies Press,
  4. Washington, DC. USA. (2005)
  5. DiVito, D. M., & Meyers, R. M. (2012). Nutrition Assessment of Children With Neuromuscular Disease at The Children's Hospital of Philadelphia. Clinical Nutrition, 27(3), 206-217.
  6. Dror Kraus, B. L. (2016). Constipation in Duchenne Muscular Dystrophy: Prevalence, Diagnosis, and Treatment. J Pediatr, 171, 183-8.
  7. Elliott SA, Davidson ZE, Davies PS, Truby H. Predicting resting energy expenditure in boys with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2012;16:631–35.
  8. Gian Paolo Ramelli, A. A. (2007). Gastrostomy placement in paediatric patients with neuromuscular disorders: indications and outcome. Dev Med Child Neurol, 49(5), 367-71.
  9. Gürcistan E Moore, A. W. (2016). Describing nutrition in spinal muscular atrophy: A systematic review. Neuromuscul Disord, 26(7), 395-404.
  10. Gürsoy S., E. M. (2016). Duchenne Musküler Distrofi Tedavisindeki Stratejiler. Türkiye Klinikleri Pediatrik Bilimler, 12(4), 60-66.
  11. H W van Bruggen, L. V.-H. (2015). Reduced mandibular range of motion in Duchenne Muscular Dystrophy: predictive factors. J Oral Rehabil, 42(6), 430-8.
  12. Hatice Tuğçe Berberoğlu, N. A. (2021). Duchenne Kas Distrofisi Olan Hastalarda Beslenme Sorunları. Biyomedikal Bilimsel ve Teknik Araştırma Dergisi, 34(5), 27105-27111. Institute of Medicine. Dietary reference intakes—the essential guide to nutrient requirements. Washington, DC: The National Academies Press; 2006. J Davo